ACPA Alleviates Bleomycin-Induced Pulmonary Fibrosis by Inhibiting TGF-β-Smad2/3 Signaling-Mediated Lung Fibroblast Activation

Pulmonary fibrosis is a group of life-threatening diseases with limited therapeutic options. The involvement of cannabinoid type 1 receptors (CB(1)R) has been indicated in fibrotic diseases, but whether or not the activation of CB(1)R can be a benefit for fibrosis treatment is controversial. In this...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Dongxin, Tang, Huirong, Jiang, Hongchao, Sun, Lei, Zhao, Wenjuan, Qian, Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8959577/
https://www.ncbi.nlm.nih.gov/pubmed/35355726
http://dx.doi.org/10.3389/fphar.2022.835979

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8959577/
https://www.ncbi.nlm.nih.gov/pubmed/35355726
http://dx.doi.org/10.3389/fphar.2022.835979

Ejemplares similares